Using a spontaneous model of mammary carcinoma, investigators identified bone marrow (BM) mesenchymal stem cells (MSCs) as the first sensors of distal cancer cells and key mediators of BM reprogramming.
[Cancer Research]
Home Newsletters Cancer Stem Cell News ATF3 Reprograms the Bone Marrow Niche in Response to Early Breast Cancer...
